Search

everythinglearnresearchcommunity

for

Search:↓

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Tamoxifen caused hair loss in a 52-year-old woman.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Breast cancer may be detectable through changes in scalp hair lipids.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

The document explains breast development, common breast conditions, and their treatments.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.